Attention-deficit/hyperactivity disorder (ADHD)
- 3.5k Downloads
The proposed revision of the diagnostic criteria in DSM-5 for attention-deficit/hyperactivity disorder (ADHD) will not fundamentally change the concept of ADHD. This is mainly due to the fact that, DSM-5 will retain the exact DSM-IV wording of all 18 symptoms, but will add new examples that make the criteria more appropriate for children, adolescents and adults. The age of onset will also be changed from 7 to 12 years, the subtyping of the disorder will change, and pervasive developmental disorders will no longer be an exclusion criterion. Although the main concept is unchanged, the suggested changes will most likely increase the prevalence of ADHD, especially in adults and adolescents, but maybe also in children. The added examples will also result in necessary revisions and new validations of rating scales and diagnostic interviews. This review will examine each of the proposed DSM-5 changes and the impact they may have, and in addition, the paper will make an overview of the main characteristics of some of the international and national guidelines for assessment and treatment of ADHD and how these impact the clinical practice.
KeywordsAttention-deficit/hyperactivity disorder (ADHD) Diagnostic classification Pervasive developmental disorder Clinical guidelines
Conflict of interest
Within the last 3 years Dr. Dalsgaard had no disclosures of conflicts of interest (2010–2012), but in 2008 and 2009, Dr. Dalsgaard received speaker’s fees from Eli Lilly and Novartis.
This article is part of the supplement “The Future of Child and Adolescent Psychiatry and Psychology: the Impact of DSM 5 and of guidelines for assessment and treatment”. This supplement was not sponsored by outside commercial interests.
- 1.American Psychiatric Association (2012) DSM-5 Development: ADHD and Disruptive Behavior Disorders. http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=383
- 5.Dopfner M, Banaschewski T, Krause J, Skrodzki K (2010) Management of children, adolescents and adults with attention deficit/hyperactivity disorder (ADHD) in Germany. Position of the central adhd network for 2009 special expert assessment by the medical expert on evaluation of development in public health. Zeitschrift fur Kinder- und Jugendpsychiatrie und Psychotherapie 38:131–136PubMedCrossRefGoogle Scholar
- 7.Kessler RC, Adler L, Barkley R, Biederman J, Conners CK, Demler O, Faraone SV, Greenhill LL, Howes MJ, Secnik K, Spencer T, Ustun TB, Walters EE, Zaslavsky AM (2006) The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry 163:716–723PubMedCrossRefGoogle Scholar
- 10.Lionel AC, Crosbie J, Barbosa N, Goodale T, Thiruvahindrapuram B, Rickaby J, Gazzellone M, Carson AR, Howe JL, Wang Z, Wei J, Stewart AF, Roberts R, McPherson R, Fiebig A, Franke A, Schreiber S, Zwaigenbaum L, Fernandez BA, Roberts W, Arnold PD, Szatmari P, Marshall CR, Schachar R, Scherer SW (2011) Rare copy number variation discovery and cross-disorder comparisons identify risk genes for ADHD. Sci Transl Med 3:95ra75PubMedCrossRefGoogle Scholar
- 12.National Board of Health (2007) Clinical guidelines for pharmacological treatment of children and adolescents with psychiatric disorders [Vejledning om medikamentel behandling af børn og unge med psykiske lidelser]. VEJ nr 10332 af 10/12/2007 National Board of Health [Sundhedsstyrelsen], CopenhagenGoogle Scholar
- 13.National Board of Health (2008) Clinical guidelines for the prescription of classified drugs [Vejledning om ordination af afhængighedsskabende lægemidler]. VEJ nr 38 af 18/06/2008. National Board of Health [Sundhedsstyrelsen], CopenhagenGoogle Scholar
- 14.National Institute for Health and Clinical Excellence (2008) NICE clinical guideline 72: attention deficit hyperactivity disorder: Diagnosis and management of ADHD in children, young people and adults. National Institute for Health and Clinical Excellence, NICEGoogle Scholar
- 17.Taylor E, Dopfner M, Sergeant J, Asherson P, Banaschewski T, Buitelaar J, Coghill D, Danckaerts M, Rothenberger A, Sonuga-Barke E, Steinhausen HC, Zuddas A (2004) European clinical guidelines for hyperkinetic disorder—first upgrade. Eur Child Adolesc Psychiatry 13(Suppl 1):I7–I30PubMedGoogle Scholar
- 18.The Danish Child and Adolescent Psychiatric Association [Børne- og Ungdomspsykiatrisk Selskab i Danmark] (2012) Clinical guidelines for assessment and treatment of children and adolescents with ADHD. BUP-DKGoogle Scholar
- 19.The Danish Child and Adolescent Psychiatric Association [Børne- og Ungdomspsykiatrisk Selskab i Danmark] (2008) The reference programme for assessment and treatment of children and adolescents with ADHD. BUP-DKGoogle Scholar